Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-05 Sale |
2025-02-07 4:37 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $30.03 | $300,300 | 109,766 (Direct) |
View |
| 2024-09-20 Sale |
2024-09-24 8:24 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
42,068 | $29.03 | $1,221,133 | 118,070 (Direct) |
View |
| 2024-05-02 Sale |
2024-05-03 6:29 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
1,718 | $18.91 | $32,487 | 18,631 (Direct) |
View |
| 2024-02-07 Sale |
2024-02-09 5:42 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $20.03 | $200,258 | 456,271 (Direct) |
View |
| 2023-05-02 Sale |
2023-05-03 6:26 pm |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
1,747 | $8.9049 | $15,557 | 17,437 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-05 Exercise |
2025-02-07 4:37 pm |
2024-12-03 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $0 | 109,766 (Direct) |
View |
| 2025-02-05 Exercise |
2025-02-07 4:37 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $1.93 | 109,766 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 8:24 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
42,068 | $0 | 118,070 (Direct) |
View |
| 2024-09-20 Exercise |
2024-09-24 8:24 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
42,068 | $1.93 | 118,070 (Direct) |
View |
| 2024-08-12 Option Award |
2024-08-14 4:14 pm |
N/A 2034-08-12 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
161,875 | $0 | 161,875 (Direct) |
View |
| 2024-05-01 Exercise |
2024-05-03 6:29 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
5,208 | $0 | 18,631 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:42 pm |
N/A 2030-12-15 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $0 | 456,271 (Direct) |
View |
| 2024-02-07 Exercise |
2024-02-09 5:42 pm |
N/A N/A |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
10,000 | $1.93 | 456,271 (Direct) |
View |
| 2023-08-17 Option Award |
2023-08-18 7:13 pm |
N/A 2033-08-17 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
220,000 | $0 | 220,000 (Direct) |
View |
| 2023-05-01 Exercise |
2023-05-03 6:26 pm |
N/A 2032-05-01 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
5,208 | $0 | 17,437 (Direct) |
View |
| 2022-08-08 Option Award |
2022-08-10 5:42 pm |
N/A 2032-08-08 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-05-01 Option Award |
2022-05-03 4:14 pm |
N/A 2025-05-01 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
15,625 | $0 | 15,625 (Direct) |
View |
| 2021-08-17 Option Award |
2021-08-19 5:09 pm |
N/A 2031-08-17 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
140,000 | $0 | 140,000 (Direct) |
View |
Ownership |
2021-03-25 9:35 pm |
N/A 2030-09-21 |
Edgewise Therapeutics Inc. | EWTX | Derakhshan Behrad Chief Business Officer |
0 | $0 | 443,180 (Direct) |
View |